Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

54results about How to "Crystal stable" patented technology

Purification method and purification device for crystallized magnesium

The invention discloses a purification method and a purification device for crystallized magnesium, and relates to the field of magnesium metal smelting. The method comprises the following steps: under the protection of an inert atmosphere, firstly carrying out pressure-applying melting treatment on a magnesium material to be smelted, and then carrying out pressure-applying filtering treatment on a product obtained after the melting treatment, so as to complete the flux-free smelting process of the magnesium material. And meanwhile, the metal magnesium liquid and most of the oxide shells are separated by utilizing the liquidity difference between the liquid metal magnesium and the solid oxide shells. Compared with a conventional smelting process without pressure application, the method has the advantages that the melting rate of the crystallized magnesium can be remarkably increased, most of oxide impurities are removed, a series of pollution problems caused by flux use are solved from the source, and low-cost, high-efficiency and high-quality smelting of the crystallized magnesium is realized.
Owner:XI AN JIAOTONG UNIV

Regenerated carbon black reinforcing agent and preparation method thereof

The invention relates to the technical field of carbon black preparation, and particularly discloses a regenerated carbon black reinforcing agent and a preparation method thereof, the regenerated carbon black reinforcing agent comprises the following raw materials by weight: 10-50 parts of a vulcanization accelerator, 2.5-12 parts of stearic acid, 2-10 parts of tackifying resin, 0.5-3 parts of modified nano zinc oxide, 0.2-2 parts of calcium sulfate whisker, 0.2-2 parts of white carbon black, 4-18 parts of carbon black and 1-5 parts of a modified silane coupling agent. The regenerated carbon black reinforcing agent provided by the invention is a high-performance modifier, when the regenerated carbon black reinforcing agent is used for modification treatment of the cracked carbon residues, the reinforcing performance of the cracked carbon residues can be efficiently improved, the 300% tensile strength and the tensile strength can meet the standards of reinforcing agents, and the regenerated carbon black reinforcing agent can replace part of commercial carbon black to be used as a reinforcing agent and has a relatively high application prospect.
Owner:JINAN DAFUER TRADING CO LTD

Dapagliflozin pharmaceutical composition as well as preparation method and application thereof

The invention belongs to the field of medicines, and particularly discloses a dapagliflozin pharmaceutical composition, the pharmaceutical composition contains dapagliflozin, a stabilizer and at least one pharmaceutically acceptable excipient, and the weight ratio of dapagliflozin to the stabilizer is not less than 20000: 1. The invention also comprises preparation and application of the pharmaceutical composition. According to the dapagliflozin pharmaceutical composition disclosed by the invention, the dapagliflozin pharmaceutical composition has excellent stability.
Owner:HUNAN JIUDIAN PHARMA CO LTD

Low-temperature denitration MgMn2O4 spinel catalyst as well as preparation method and application thereof

The invention discloses a low-temperature denitration MgMn2O4 spinel catalyst as well as a preparation method and application thereof. The catalyst has the shape of a hollow quadrangular prism, and is prepared by dispersing magnesium salt and manganese salt by using hexadecyl trimethyl ammonium bromide as a dispersing agent, then mixing with oxalic acid or sodium oxalate, carrying out hydrothermal reaction at 140-160 DEG C, carrying out vacuum drying on a reaction product, and calcining in an oxidizing atmosphere. When the catalyst is used for low-temperature denitration, the low-temperature catalytic effect is remarkable, and the catalyst is free of biological toxicity, low in cost, simple in preparation method and wide in application prospect.
Owner:WUHAN UNIV OF TECH

Metal organic framework material as well as preparation method and application thereof in methane adsorption

The invention discloses two metal organic framework materials Zr-TTB-1 and Zr-TTB-2, a preparation method of the two metal organic framework materials, and an application of the two metal organic framework materials in methane adsorption. The preparation method comprises the following steps: firstly, synthesizing an organic ligand TTB containing a five-membered thiophene ring by taking 1, 3, 5-tri (thiophene-2-yl) benzene as a raw material under specific and appropriate conditions, and then preparing two stable metal organic framework materials from the organic ligand TTB and Zr6 metal clusters under specific and appropriate conditions. The synthesis and preparation method is simple in route, easy to operate, low in cost and suitable for efficient methane adsorption and storage.
Owner:ZJU HANGZHOU GLOBAL SCI & TECH INNOVATION CENT

System and method for producing and storing solid hydrogen at low temperature by using porous medium

The invention discloses a system and a method for producing and storing solid hydrogen at low temperature by using a porous medium, the system comprises a porous medium storage unit, a hydrogen compressor, a refrigerating system, a control system and a hydrogen supply and recovery system, and a crystal coating of an HCP or an FCC is constructed by using the pore surface of the porous medium; hydrogen is injected into a porous medium material with a high specific surface area and good adsorption performance under high pressure, the pressure is controlled to be 10-1000 Mpa, the temperature of the hydrogen is reduced to-75 DEG C to-240 DEG C, crystallization and solidification of the hydrogen on the surface of the porous medium are achieved under the low-temperature and high-pressure conditions, a control system monitors and adjusts parameters such as the temperature and the pressure in the system in real time, and the hydrogen can be recycled. The safety and reliability of the hydrogen storage process are ensured, when hydrogen needs to be released, the control system enables the hydrogen to be released from the porous medium in a temperature rise or pressure reduction mode, and the hydrogen is recovered and utilized through the hydrogen supply and recovery system.
Owner:SUZHOU UNIV

Preparation method of anhydrous beta-lactose with high yield and low color value

The invention relates to the technical field of saccharide purification, in particular to a high-yield and low-color-value anhydrous beta-lactose preparation method which comprises the following steps: preparing a lactose solution by taking food-grade lactose as a raw material, adding activated carbon for adsorption, then carrying out column treatment to remove nitrogen-containing inorganic salt and organic acid, and finally carrying out film evaporation concentration to separate out beta-lactose crystals. The method comprises the following steps of: adding anhydrous beta-lactose into a reaction kettle, automatically scraping off crystals, and collecting to obtain anhydrous beta-lactose, the yield of the anhydrous beta-lactose is at least 90wt%, and the color value is lower than 25. According to the method, the yield of the beta-lactose can be improved, and the produced beta-lactose is uniform in particle size, normal in color and few in impurities.
Owner:SINOPHARM CHEM REAGENT +1

Use of drug-coated balloon in treatment of peripheral vascular atherosclerosis, stenosis and / or restenosis

The invention provides an application of a drug-coated balloon in treatment of peripheral vascular atherosclerosis, stenosis and / or restenosis. The coating liquid of the drug-coated balloon comprises a water-phase solvent and further comprises a plurality of core-shell structures formed by wrapping drugs with phospholipid bimolecular layers, the core-shell structures are dispersed in the water-phase solvent, the inner core of each core-shell structure comprises a plurality of particles loaded with the drugs, and the outer core of each core-shell structure comprises a plurality of particles loaded with the drugs. The shell of the core-shell structure is the phospholipid bilayer, the phospholipid bilayer comprises hydrophilic groups on the outer layer and hydrophobic groups on the inner layer, and the plurality of particles loaded with the medicine comprise a plurality of nanocrystalline particles containing the medicine. According to the invention, the nanocrystal is combined with the liposome, and the advantages of two drug carriers are combined; the formed phospholipid bilayer increases the solubility of the insoluble drug on the drug-coated balloon, the drug loading capacity is high, the drug carrier stability is good, and the drug crystal form is stable, so that the drug release rate is controllable.
Owner:CARDIO NAVI MEDTECH (WUHAN) CO LTD

MOR molecular sieve membrane and preparation method thereof

The present invention provides a MOR molecular sieve membrane and a preparation method thereof, wherein the preparation method of the MOR molecular sieve membrane comprises the following steps: S1, mixing an aluminum source, an alkali solution, a silicon source, a fluoride salt, an organic alcohol and water to obtain a synthetic sol; S2, coating a seed solution on the surface of a porous carrier to obtain a seed layer; S3, coating the synthetic sol on the surface of the seed layer, and performing three temperature-variable crystallizations to obtain a MOR molecular sieve membrane; in step S1, the molar ratio of SiO2, Na2O, Al2O3, ROH, NaF and H2O is 1: (0.1-0.35): (0.03-0.15): (0.2-2): (0.1-0.5): (10-100). The present invention adds an organic alcohol to improve the crystallinity and overall structural integrity of the MOR molecular sieve membrane structure.
Owner:WUHAN ZHSB ENVIRONMENTAL TECHNOLOGY CO LTD

Separation and purification method of 3-fucosyllactose

The invention belongs to the technical field of separation and purification, and particularly relates to a separation and purification method of 3-fucosyllactose. According to the method disclosed by the invention, the 3-FL can be efficiently separated and purified through two crystallization processes by controlling the proper graining temperature, associating the graining sugar degree with the two times of seed crystal adding time and controlling the cooling crystallization rate, so that a high-quality 3-FL crystallization product is obtained. The method is simple and convenient, is more suitable for industrial production, and can be used for extracting and purifying high-quality 3-FL only through simple and conventional pretreatment steps; more widely, the method can be used for extracting high-quality 3-FL from a crude 3-fucosyllactose solution prepared by an enzyme method and a chemical synthesis method.
Owner:TIANJIN HESHENG NAVIGATION BIOTECHNOLOGY CO LTD

Lamidetan solid preparation and preparation method thereof

The invention belongs to the technical field of medicines, and particularly provides a lamidetan solid preparation and a preparation method thereof. The lamidetan solid preparation is prepared from the following raw materials: lamidetan, an anti-adsorbent, a filling agent, a disintegrating agent and a lubricating agent, the preparation method of the lamidetan comprises a powder direct compression method and a dry granulation method. The lamidetan solid preparation provided by the invention can solve the problem of adhesion of raw materials, keeps that the raw material medicines exist in a single crystal form in a stability investigation process, and is stable in content, rapid in disintegration and suitable for industrial production.
Owner:SHANDONG NEW TIME PHARMA CO LTD

A crystal of IRAK4 inhibitor and preparation method thereof

Provided are a crystal of a compound of formula (I), a salt thereof, a crystal of the salt thereof, and a method for preparing the crystal, and also include use of the compound and the crystal in preparing a drug for treating IRAK4-related diseases.
Owner:CHIA TAI TIANQING PHARMA GRP CO LTD

Pharmaceutical preparation of ceftriaxone sodium compound and preparation method thereof

The invention provides a pharmaceutical preparation of a cefotaxime sodium compound and a preparation method thereof. The preparation method comprises the following steps: S1, weighing 20.0 g of sodium acetate trihydrate, putting the mixture into a reactor, adding 40.0 mL of a crystallization solvent, stirring and dissolving the mixture for 10 minutes, and obtaining a sodium acetate trihydrate solution; S2, adding cefotaxime acid to the sodium acetate trihydrate solution, and obtaining a clear and transparent reaction solution after the salt-forming reaction is complete; S3, moving the reaction solution into a crystallizer, dripping 0.5-2 mL of a 40% alkyl glycoside aqueous solution into the crystallizer, and starting stirring; S4, starting a constant temperature ice machine, and starting to drip a dissolving agent when the solution temperature in the crystallizer reaches 20-24° C., adding a seed crystal when the solution is slightly turbid, growing the crystal for 30 minutes, and continuing to drip a dissolving agent, and adding a total of 265 mL of a dissolving agent; S5, after the dissolving and crystallization is completed, vacuum filtration is performed, and drying is performed to obtain the cefotaxime sodium compound. The present invention reduces supersaturation, reduces nucleation barriers, and weakens spontaneous nucleation through the participation of 40% alkyl glycoside aqueous solution, so as to obtain a product with a large average particle size and concentrated particle size distribution.
Owner:上海欣峰制药有限公司

A process for purifying and recycling industrial wastewater

PendingCN122079410Acrystal stableSolve easy foulingWater contaminantsMultistage water/sewage treatmentWater useIn situ crystallization
This invention relates to the field of water pollution purification, specifically to a process for purifying and recycling industrial wastewater. The process provided by this invention induces the in-situ crystallization and precipitation of calcium and magnesium ions, primarily in the form of aragonite-type calcium carbonate, by adding a crystal form regulator to the wastewater. This replaces the traditional precipitation method using precipitants, fundamentally preventing the generation of secondary sludge. Simultaneously, a quencher regulates the type and concentration of active free radicals within the system, achieving targeted degradation of organic matter while maximizing the retention of beneficial ions in the water, ensuring the corrosion inhibition performance of the recycled water. This invention features a simple operation, requires no mechanical structural modifications, and can be directly adapted to existing industrial water treatment systems. It effectively solves the problem of simultaneously addressing hardness removal and organic matter degradation in circulating water wastewater treatment, significantly improving the purification and recycling efficiency of wastewater. The treated effluent can be directly reused in industrial circulating water systems.
Owner:JIANGSU AIR WATER ENVIRONMENTAL PROTECTION SCI & TECH CO LTD

Solid form of compound

The invention relates to the field of medicine crystal forms, in particular to salt forms of lysine-specific demethylase-1 inhibitor compounds with the structure shown in the formula I, crystal forms of various salts and preparation methods of the salt forms and the crystal forms. The benzene sulfonate crystal form A and the benzene sulfonate crystal form B of the compounds shown in the formula I have good physical and chemical stability and crystal form stability, and the preparation process is simple and good in repeatability. The method is high in yield, environment-friendly, easy to operate, convenient to recycle and easy to realize large-scale production.
Owner:CHENGDU EASTON BIOPHARMACEUTICALS CO LTD

MOR molecular sieve membrane and preparation method thereof

The invention provides an MOR molecular sieve membrane and a preparation method thereof.The preparation method of the MOR molecular sieve membrane comprises the following steps that S1, an aluminum source, alkali liquor, a silicon source, villiaumite, organic alcohol and water are mixed, and synthetic sol is obtained; s2, coating the surface of the porous carrier with a seed crystal liquid to obtain a seed crystal layer; s3, coating the synthetic sol on the surface of a seed crystal layer, and carrying out three times of variable-temperature crystallization to obtain an MOR molecular sieve membrane; in the step S1, the molar ratio of the SiO2 to the Na2O to the Al2O3 to the ROH to the NaF to the H2O is 1 to (0.1 to 0.35) to (0.03 to 0.15) to (0.2 to 2) to (0.1 to 0.5) to (10 to 100). The organic alcohol is added, so that the crystallinity of the MOR molecular sieve membrane structure and the integrity of the whole structure are improved.
Owner:WUHAN ZHSB ENVIRONMENTAL TECHNOLOGY CO LTD

A crystal form of a cyano-substituted polypeptide compound and a preparation method thereof

The present invention discloses a crystal form of a polypeptide compound containing cyano substitution and a preparation method thereof, specifically discloses a crystal form of a compound of formula (I) and a preparation method thereof.
Owner:FUJIAN AKEYLINK BIOTECHNOLOGY CO LTD

An easily filled iron-based parahydrogen conversion catalyst, a preparation method thereof, and application in parahydrogen catalytic conversion

The invention discloses an easy-to-fill iron-based normal para-hydrogen conversion catalyst and its preparation method and application in normal para-hydrogen catalytic conversion. The preparation process of the iron-based normal para-hydrogen conversion catalyst is as follows: under stirring, alkali solution is added dropwise to an iron salt solution or an iron salt solution doped with other metal salts to adjust the pH to 8.5-10.5, and the solution is allowed to stand for aging. After aging, the pH is neutralized with a regulator to 6.5-7.5, and a bulk normal para-hydrogen conversion catalyst precursor is obtained by washing and drying; the bulk normal para-hydrogen conversion catalyst precursor is crushed into a fine powder, mixed with a binder, and then put into a granulator in batches for spray granulation, and dried and sieved to obtain a spherical or spherical catalyst with a particle size of 20-50 mesh; wherein the mass ratio of the fine powder to the binder is 1:0.03-0.35; the iron-based normal para-hydrogen conversion catalyst is a mixture of α-Fe2O3 and FeOOH doped or not doped with other metal elements.
Owner:TECHNICAL INST OF PHYSICS & CHEMISTRY - CHINESE ACAD OF SCI

Dapagliflozin and metformin sustained release tablet and preparation method thereof

The invention discloses a dapagliflozin and metformin sustained release tablet and a preparation method thereof. The sustained release tablet comprises dapagliflozin, metformin or hydrochloride thereof, a crystal form stabilizer and a sustained release material. The dapagliflozin sustained-release tablet at least can guarantee crystal form stability for 24 months, the crystal form of dapagliflozin is stable in the whole effective period, the medicine effect is consistent, and the clinical medication effect is guaranteed. The sustained-release tablet provided by the invention has the advantages of small dosage of sustained-release materials, small tablet weight and small tablet volume, and is easier for patients to take. According to the sustained release tablet, the preparation process is simplified, the production difficulty and cost are reduced, and the production efficiency is improved.
Owner:SHANDONG KANGMEILE MEDICAL TECH CO LTD

Method for inhibiting oxygen vacancy of yttrium oxide coating

The invention discloses a method for inhibiting oxygen vacancy of an yttrium oxide coating, which comprises the following steps: doping a dispersion stabilizer into Y2O3 powder, uniformly stirring to obtain a suspension, and sanding to obtain dispersion stabilizer-doped yttrium oxide slurry; carrying out spray drying on the yttrium oxide slurry doped with the dispersion stabilizer obtained after sanding, and granulating to obtain spherical yttrium oxide powder, wherein the particle size of the spherical yttrium oxide powder is controlled to be 42 + / -3 microns; calcining spherical particle yttrium oxide powder obtained after granulation at the temperature of 1500-1600 DEG C, screening the calcined powder, and removing powder with the particle size of less than 20 microns and powder with the particle size of more than 63.5 microns to obtain dispersion stabilizer doped yttrium oxide powder with the D50 of 35 + / -3 microns; a dispersion stabilizer doped yttrium oxide powder material is sprayed on a base material by adopting a plasma spraying technology to form the yttrium oxide spraying coating. The method can effectively inhibit the yttrium oxide powder from generating oxygen vacancy in the sanding process.
Owner:CHONGQING GENORI IND CO LTD

Application of drug-coated balloon in treatment of coronary atherosclerosis, stenosis and / or restenosis

The invention provides an application of a drug-coated balloon in treatment of coronary atherosclerosis, stenosis and / or restenosis. The coating liquid of the drug-coated balloon comprises a water-phase solvent and further comprises a plurality of core-shell structures formed by wrapping drugs with phospholipid bimolecular layers, the core-shell structures are dispersed in the water-phase solvent, the inner core of each core-shell structure comprises a plurality of particles loaded with the drugs, and the outer core of each core-shell structure comprises a plurality of particles loaded with the drugs. The shell of the core-shell structure is the phospholipid bilayer, the phospholipid bilayer comprises hydrophilic groups on the outer layer and hydrophobic groups on the inner layer, and the plurality of particles loaded with the medicine comprise a plurality of nanocrystalline particles containing the medicine. According to the invention, the nanocrystal is combined with the liposome, and the advantages of two drug carriers are combined; the formed phospholipid bilayer increases the solubility of the insoluble drug on the drug-coated balloon, the drug loading capacity is high, the drug carrier stability is good, and the drug crystal form is stable, so that the drug release rate is controllable.
Owner:CARDIO NAVI MEDTECH (WUHAN) CO LTD

4D printing PLA / TPU composite material based on cold crystallization as well as preparation method and application thereof

The invention provides a 4D printing PLA / TPU composite material based on cold crystallization as well as a preparation method and application thereof. The composite material is prepared from the following raw materials in percentage by mass: 50 to 100 percent of polylactic acid and 0 to 50 percent of thermoplastic polyurethane. The preparation method comprises the following steps: carrying out vacuum drying treatment on polylactic acid and thermoplastic polyurethane, uniformly mixing according to a ratio, putting into a double-screw extruder, and carrying out melt blending, extrusion and molding to obtain the composite filament. The composite filament meets the material requirements of fused deposition modeling (FDM) 3D printing, and is used for preparing 3D models such as intelligent structures and orthotics. The 3D model shows excellent shape memory performance, high mechanical strength and crystallization capacity. A 3D printing technology is utilized to construct a three-dimensional model, and a cold crystallization process and a 4D printing technology are combined, so that the PLA / TPU composite material can realize transformation from a temporary shape to a second permanent shape under external stimulation, and has an intelligent response function.
Owner:SICHUAN NORMAL UNIV

Flow adjusting structure of phosphor copper solder production crystallizer

The utility model relates to phosphor copper brazing filler metal production equipment technical field especially relates to a kind of phosphor copper brazing filler metal production crystallizer flow regulating structure, including machine body, machine body is opened in crystallization cavity, and the through-hole is opened in axial two ends, the top of crystallization cavity is fixedly connected with feed pipe, the top of feed pipe is fixedly connected with adjusting pipe, the inner ring surface of adjusting pipe is fixedly connected with circular column, one end of circular column towards feed pipe is opened with moving groove, slidingly connected with sliding cylinder in moving groove, the outer ring surface of sliding cylinder is opened with multiple evenly distributed filter holes, flow sensor can real-time monitoring the flow condition of phosphor copper liquid, realize stable movement under the cooperation of guide column, to accurately adjust the flow of feed pipe, filter hole on sliding cylinder can intercept metal impurities, reduce equipment cost, simultaneously, the structure realizes the automatic regulation of flow, without manual intervention, reduce the error and hysteresis brought by human operation, and then improve the production quality and efficiency of phosphor copper brazing filler metal.
Owner:XINXIANG QIXING BRAZING TECH CO LTD

Device and method for preparing type II anhydrite from phosphogypsum and preventing skinning

The invention provides a device and a method for preparing type II anhydrous gypsum from phosphogypsum and preventing crust, the device comprises a preheating drying unit, a calcining unit and a cooling separation unit, the preheating drying unit comprises a drying crushing device and at least one stage of preheating separation device; the calcining unit comprises a vertical calcining furnace, the lower part of the vertical calcining furnace is conical, the diameter is gradually reduced from top to bottom, and the side wall is provided with a feed port and multiple layers of combustion nozzles; and a solid phase outlet pipeline of the cooling separation unit is divided into two branches, one branch is connected with the vertical calcining furnace, and the other branch is a finished product collecting pipeline. According to the invention, through the arrangement of the preheating drying unit, the calcining unit, the cooling separation unit and other structural units, moisture is removed through preheating drying, easily-skinning components in the raw materials are taken away in advance, and through the design of the vertical calcining furnace, the temperature is accurately controlled, burning melting and skinning are avoided, and impurities are effectively removed, so that the high-quality II-type anhydrous gypsum is obtained; the device is reasonable in structural design, stable in operation and high in phosphogypsum utilization rate, and the application market of the device can be expanded.
Owner:HUBEI YIFU JINCHU NEW MATERIALS CO LTD

Method for high-efficiency recovery of sodium acetate in acephate wastewater and biochemical carbon source

The application relates to the technical field of wastewater treatment, and particularly discloses a high-efficiency recovery and biochemical carbon source method for sodium acetate in acephate wastewater. The high-efficiency recovery and biochemical carbon source method for sodium acetate in acephate wastewater comprises the following steps: solvent recovery, high-temperature hydrolysis, methanol recovery and evaporation concentration are performed on acephate wastewater to obtain a salt-containing concentrated mother liquor and condensate water A; the salt-containing concentrated mother liquor is subjected to centrifugal separation to separate out a mixed salt containing sodium sulfate and sodium phosphate, and a salt-separated mother liquor is obtained; the salt-separated mother liquor is continuously cooled and crystallized to obtain a crystal slurry containing sodium acetate crystals; the crystal slurry containing the sodium acetate crystals is subjected to centrifugal separation to obtain a sodium acetate product and a crystallization mother liquor; part of the crystallization mother liquor is returned to a sodium acetate crystallization system to adjust the solid content of the crystal slurry, and the other part is subjected to drying treatment to obtain a mixed salt and condensate water B; the condensate water A and the condensate water B are sent to a biochemical system for treatment, and treated water is obtained.

Cotton stalk graphene induction device integrating vacuum environment and adsorption system

PendingCN121974336Aavoid burnsAchieve the effect of fully automatic continuous production of grapheneGrapheneGrapheneRotating disc
The invention relates to the technical field of graphene production equipment, and discloses a vacuum environment and adsorption system integrated cotton stalk graphene induction device which comprises a control console, a smashing mechanism, a conveying table and a vacuum system are fixed to the upper surface of the control console, and a supporting frame is fixed to the upper surface of the control console; a first electric push rod is fixed to the inner wall of the supporting frame, a rotating disc is fixedly arranged at the output end of the servo motor, the outer wall of the rotating disc rotates on the inner wall of the control table, multiple sets of sealing boxes are arranged on the upper surface of the rotating disc, and a discharging assembly is arranged on the upper surface of the control table. Cotton stalks are poured into the smashing mechanism and mixed and smashed with salt materials, at the moment, the cotton stalks are put into the sealing box to be subjected to vacuum treatment, the cotton stalks are prevented from being burnt, the sealing box is matched with the sealing assembly, and by-products can be adsorbed while vacuum treatment is conducted; and the servo motor is matched with the turntable, so that the effect of full-automatic continuous production of graphene can be achieved.
Owner:TARIM UNIV

Portland cement clinker based on marlstone and preparation method thereof

The invention discloses portland cement clinker based on marlstone and a preparation method thereof, and relates to the technical field of cement. The method comprises the following steps: crushing, grinding and drying natural marlstone, spraying and activating by using a mixed steeping liquor containing sodium hydroxide, lanthanum nitrate and cerous nitrate, and drying and roasting at low temperature to obtain modified marlstone powder; mixing the powder with calcium carbonate, quartz powder, ferric oxide, dihydrate gypsum, calcium fluoride and barium carbonate, and pressing into a green body; and finally, sequentially carrying out two-stage mineralization calcination on the green body, introducing oxygen-enriched air in a heat preservation stage, continuously calcining, and cooling to obtain the cement clinker. According to the invention, marlstone is used as a main raw material, and the obtained cement clinker has excellent sulfate corrosion resistance through dipping activation and multi-stage calcination processes.
Owner:HUBEI BAIZHAOSHAN CEMENT CO LTD

Application of drug-coated balloon in treatment of intracranial artery atherosclerosis, stenosis and / or restenosis

The invention provides an application of a drug-coated balloon in treatment of intracranial atherosclerosis, stenosis and / or restenosis of artery blood vessels. The coating liquid of the drug-coated balloon comprises a water-phase solvent and further comprises a plurality of core-shell structures formed by wrapping drugs with phospholipid bimolecular layers, the core-shell structures are dispersed in the water-phase solvent, the inner core of each core-shell structure comprises a plurality of particles loaded with the drugs, and the outer core of each core-shell structure comprises a plurality of particles loaded with the drugs. The shell of the core-shell structure is the phospholipid bilayer, the phospholipid bilayer comprises hydrophilic groups on the outer layer and hydrophobic groups on the inner layer, and the plurality of particles loaded with the medicine comprise a plurality of nanocrystalline particles containing the medicine. According to the invention, the nanocrystal is combined with the liposome, and the advantages of two drug carriers are combined; the formed phospholipid bilayer increases the solubility of the insoluble drug on the drug-coated balloon, the drug loading capacity is high, the drug carrier stability is good, and the drug crystal form is stable, so that the drug release rate is controllable.
Owner:CARDIO NAVI MEDTECH (WUHAN) CO LTD

Tagatose crystal form and preparation process thereof

The invention relates to the technical field of tagatose, in particular to a tagatose crystal form and a preparation process thereof, the tagatose crystal form has characteristic diffraction peaks when the diffraction angles 2 theta are 9.94 + / -0.02, 14.43 + / -0.02, 15.04 + / -0.02, 17.36 + / -0.02, 19.69 + / -0.02, 19.98 + / -0.02, 20.28 + / -0.02, 22.09 + / -0.02, 24.59 + / -0.02, 24.79 + / -0.02, 28.18 + / -0.02, 29.11 + / -0.02, 30.17 + / -0.02, 30.88 + / -0.02, 31.30 + / -0.02, 32.07 + / -0.02, 32.53 + / -0.02, 33.38 + / -0.02, 34.49
Owner:ZHUCHENG HAOTIAN PHARMA CO LTD